Journals / Gülhane Tıp Dergisi / 2022 / Cilt: 64 - Sayı: 1

Monitoring of gentamicin blood level in one-week-of-life neonates admitted to a special care nursery ward

Pages
27–31
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The decision of not determining the peak levels routinely can be based on the outcome that gentamicin dosage of 4.0 mg/kg likely provides peak levels in desired range without any added risk of toxicity

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aims: Gentamicin is routinely used in neonates as an empirical antibiotic for suspected sepsis at a dose of 4.0 mg/kg, either 24 or 36 hourly based on premenstrual age.
📊
Key Findings & Data:This study was conducted to determine gentamicin blood level in one-week-of-life neonates on 4 mg/kg treatment.
💡
Conclusion & Impact:The decision of not determining the peak levels routinely can be based on the outcome that gentamicin dosage of 4.0 mg/kg likely provides peak levels in desired range without any added risk of toxicity
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aims: Gentamicin is routinely used in neonates as an empirical antibiotic for suspected sepsis at a dose of 4.0 mg/kg, either 24 or 36 hourly based on premenstrual age. Regularly, therapeutic drug monitoring is performed. This study was conducted to determine gentamicin blood level in one-week-of-life neonates on 4 mg/kg treatment. Methods: Neonates who received gentamicin in a special care nursery ward were identified from the records retrospectively. The included subjects were neonates between 3 and 7 days old treated with gentamicin for at least three days. Admission diagnoses, dosing protocol (including dosage, the timing of the doses, and timing of blood samples) and measured gentamicin trough and peak levels were recorded. Results: A total of 290 neonates met the inclusion criteria (male: 57.6%). Over 30% of the subjects treated with gentamicin experienced potential toxicity with trough levels above 1.0 μg/mL, and 15.9% of them had sub efficacy of the drug (peak level below 5 μg/mL). Six neonates had trough levels above 2.0 μg/mL. The percentage of potential toxicity was higher in subjects with presumed sepsis, in those with bodyweight between 2.5-2.99 kg and with 24- hour dosing interval. Conclusions: We propose a trough-only monitoring protocol in non-critically ill neonates, as the practice of monitoring pre and post often necessitate additional blood sampling. The decision of not determining the peak levels routinely can be based on the outcome that gentamicin dosage of 4.0 mg/kg likely provides peak levels in desired range without any added risk of toxicity

🔖

Cite This Article

MUSTAFA, S., NOOR, S. L. A. M., YUSUF, W. N. W., RAZMAN, R. (2022). Monitoring of gentamicin blood level in one-week-of-life neonates admitted to a special care nursery ward. Gülhane Tıp Dergisi, Cilt: 64 - Sayı: 1, 27–31. https://ajindex.com/articles/526760

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Kiatchoosakun P, Kosalaraksa P, Jirapradittha J, Taksaphan S, Tassniyom S. Once-Daily Gentamicin Dosing of 4 Mg / Kg / Dose in Neonates. J Med Assoc Thai. 2017;88:934-938
  2. Kosalaraksa P, Janthep P, Jirapradittha J, Taksaphan S, Kiatchoosakun P. Once versus twice daily dose of gentamicin therapy in Thai neonates. J Med Assoc Thai. 2004;87:372-376
  3. Lackner TE, Lyss AP. A simple method to estimate the initial dose of gentamicin. Pharmacotherapy. 1992;12:195-200. 4. van Donge T, Pfister M, Bielicki J, et al. Quantitative Analysis of Gentamicin Exposure in Neonates and infants calls into question its current dosing recommendations. Antimicrob Agents Chemother. 2018;62:e02004
  4. Usher R, Shephard M, Lind J. The Blood Volume of the Newborn Infant and Placental Transfusion. Acta Paediatr. 1963;52:497-512
  5. Lin JC, Strauss RG, Kulhavy JC, et al. Phlebotomy overdraw in the neonatal intensive care nursery. Pediatrics. 2000;106:19
  6. Clinical Pharmacokinetics Pharmacy Handbook. 2nd ed. Pharmacy Practice & Development Division, MOH Malaysia; 2019. https://www.pharmacy.gov.my/v2/sites/default/files/ document-upload/clinical-pharmacokinetics-pharmacyhandbook-ccph-2nd-edition-rev-2.0.pdf 8. Valitalo PA, van den Anker JN, Allegaert K, et al. Novel modelbased dosing guidelines for gentamicin and tobramycin in preterm and term neonates. J Antimicrob Chemother. 2015:70:2074-2077
  7. Mohamed AF, Nielsen EI, Cars O, Friberg LE. Pharmacokineticpharmacodynamic model for gentamicin and its adaptive resistance with predictions of dosing schedules in newborn infants. Antimicrob Agents Chemother. 2012;56:179-188
  8. Darmstadt GL, Miller-Bell M, Batra M, Law P, Law K. Extendedinterval dosing of gentamicin for treatment of neonatal sepsis in developed and developing countries. J Health Popul Nutr. 2008;26:163-182.